Advertisement

September 2016 (vol. 215, no. 3, page 395)

    Published:April 07, 2017DOI:https://doi.org/10.1016/j.ajog.2017.03.028
        Wright JD, Chatterjee S, Jones N, et al. National trends in total pelvic exenteration for gynecologic malignancies. Research Letter. Am J Obstet Gynecol 2016;215:395-6.
        The authors of a Research Letter published in September 2016 were listed in incorrect order. The correct order follows: Chatterjee S, Chen L, Jones N, Tergas AI, Burke WM, Hou JY, Wright JD.
        The authors’ affiliations are accurate as published.

        Linked Article

        • National trends in total pelvic exenteration for gynecologic malignancies
          American Journal of Obstetrics & GynecologyVol. 215Issue 3
          • Preview
            Total pelvic exenteration (TPE) is a radical procedure involving en bloc resection of the pelvic viscera. The procedure may be performed as primary treatment for gynecologic malignancies or as a salvage therapy in women with a pelvic recurrence.1,2 It is unclear how improvements in radiation and chemotherapy have impacted the use of TPE. We performed a population-based analysis to examine the annual rate of TPE among women with cervical and uterine cancer.
          • Full-Text
          • PDF